InnovAge (INNV) Projected to Post Quarterly Earnings on Tuesday

InnovAge (NASDAQ:INNV) is anticipated to issue its Q4 2026 results after the market closes on Tuesday, September 8th. Analysts expect the company to post earnings of $0.0747 per share and revenue of $238.3340 million for the quarter. Investors may review the information on the company’s upcoming Q4 2026 earning results page for the latest details on the call scheduled for Tuesday, September 8, 2026 at 5:00 PM ET.

InnovAge Price Performance

InnovAge stock opened at $10.75 on Monday. The stock has a 50-day moving average price of $11.24 and a two-hundred day moving average price of $9.29. InnovAge has a 12 month low of $3.69 and a 12 month high of $12.64. The company has a market capitalization of $1.46 billion, a PE ratio of -119.44 and a beta of 0.40. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.26.

Hedge Funds Weigh In On InnovAge

Hedge funds and other institutional investors have recently made changes to their positions in the stock. T. Rowe Price Investment Management Inc. increased its position in InnovAge by 10.3% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,168,330 shares of the company’s stock valued at $32,014,000 after purchasing an additional 577,558 shares during the period. Marshall Wace LLP acquired a new position in shares of InnovAge in the 4th quarter worth approximately $1,512,000. O Shaughnessy Asset Management LLC lifted its position in shares of InnovAge by 1,978.3% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 238,881 shares of the company’s stock worth $1,240,000 after purchasing an additional 227,387 shares during the period. Kent Lake PR LLC lifted its position in shares of InnovAge by 13.1% in the 2nd quarter. Kent Lake PR LLC now owns 1,697,036 shares of the company’s stock worth $6,262,000 after purchasing an additional 197,036 shares during the period. Finally, Welch Capital Partners LLC NY boosted its stake in shares of InnovAge by 22.6% in the 2nd quarter. Welch Capital Partners LLC NY now owns 448,775 shares of the company’s stock valued at $1,656,000 after purchasing an additional 82,868 shares during the last quarter. 12.26% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on INNV shares. Wall Street Zen lowered shares of InnovAge from a “buy” rating to a “hold” rating in a report on Sunday, May 17th. KeyCorp raised shares of InnovAge from a “sector weight” rating to an “overweight” rating and set a $13.00 target price on the stock in a report on Friday, August 21st. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of InnovAge in a research note on Thursday, August 13th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, InnovAge presently has a consensus rating of “Reduce” and an average price target of $10.00.

About InnovAge

InnovAge Holdings, Inc (NASDAQ:INNV) is a healthcare services company that specializes in caring for seniors through the Program of All-Inclusive Care for the Elderly (PACE). Designed for individuals who are eligible for both Medicare and Medicaid, the PACE model integrates medical care, social services and long-term care—delivered primarily in participants’ homes and community-based centers. InnovAge’s approach centers on interdisciplinary care teams that coordinate everything from primary and specialty medical services to nutritional counseling and recreational activities.

The company’s core offerings include comprehensive in-home assessments, physician and nursing services, physical and occupational therapy, prescription medication management, and transportation to medical appointments.